Prostate cancer is the second leading cause of cancer death among men in the United States. It is a common disease that effects 1 out of every 7 men. The good news is that early detection can assist in fighting this disease and scheduling annual prostate screenings can help identify this cancer in its early
ProstAtak® is a new prostate cancer treatment trial for localized prostate cancer using gene therapy. This new cancer treatment trial is now available at our facilities and we are one of only two medical centers in the Houston area that offer this treatment trial. Click here for more information about the treatment and how to
A Cutting Edge BPH Treatment Option Called UroLift Is Making Waves In The Urology World and Dr. Steven Sukin Is Leading The Charge in Bringing This Revolutionary Procedure to Houston and Proctoring Doctors from around The Country
A common medical condition that targets older men regarding the enlargement of the prostate gland is referred to as BPH or Benign prostate hyperplasia. Symptoms include a weak or slow urinary stream, a sense that you cannot completely empty your bladder, difficulty or delay in starting urination, an urgent feeling of needing to urinate as well
Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. Over 70% of men in their 60s have BPH symptoms so it is very common. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life. The prostate is a male
What is HIFU? HIFU stands for high intensity focused ultrasound, which is a minimally invasive technique for treating disease with precise, focused ultrasound waves that, when delivered, raise the temperature of the target tissue to nearly 195 degrees Fahrenheit in 2-3 seconds. This rapid-firing heat destroys the targeted tissue but leaves the surrounding tissue intact.